25 Feb 2021
15:29 E.S.T.

Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST

Read more

16 Feb 2021
01:00 E.S.T.

Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells

Read more

15 Dec 2020
19:18 E.S.T.

Cellectis Announces Withdrawal of Follow-On Offering

Read more

14 Dec 2020
15:48 E.S.T.

Cellectis Announces Launch of Follow-On Offering

Read more

05 Dec 2020
17:00 E.S.T.

Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting

Read more

17 Nov 2020
18:58 E.S.T.

FDA Lifts Clinical Hold on MELANI-01 Study Evaluating Cellectis’ Product Candidate UCARTCS1 in Multiple Myeloma

Read more